RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PPPilotboy, agreed that it may not be production of 20,000 units themselves. I would actually imagine that it is tied to setting yourself up to being able to get to that maximum be it at the end of April, or May or whatever. But I think the significance of that is that KNR envisions that need, or so we hope. As a number of us argued, monthly sales of a couple of thousand units see us at a double digit share price easily, not to guess at a number. There is a big difference between 20K and 2K. So, lots of confusion that in my humble opinion needs to be somewhat clarified sooner rather than later as such confusion can negatively affect many stakeholders, while helping those that the company should not be catering to.
Pilotboy246 wrote:
canyousayiii wrote: Pilotboy: "With Ontario's support, CEMSI plans to increase production capacity to 20,000 units per month. The product will be manufactured in London with more than 85 per cent of its components produced in province. The company anticipates accelerating the production of the BioCloud will create up to 250 direct jobs and up to 750 indirect jobs." THEN: "The investment funding agreement with government requires Kontrol to achieve certain production milestones and the investment funding will be issued in two tranches of $1.2 Million immediately and $800,000 on completion of the milestones by March 30th 2021." SO, we don't know what the milestones for $800,000 are, but the intention for what the money will help achieve is clearly stated.
Agreed, I'm just saying it's not a forgone conclusion that it's 20,000, that's all.